MicroRNA-542-3p inhibits tumour angiogenesis by targeting Angiopoietin-2
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-542-3p inhibits tumour angiogenesis by targeting Angiopoietin-2
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 232, Issue 5, Pages 499-508
Publisher
Wiley
Online
2014-01-09
DOI
10.1002/path.4324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Calcineurin-NFAT-Angiopoietin-2 Signaling Axis in Lung Endothelium Is Critical for the Establishment of Lung Metastases
- (2013) Takashi Minami et al. Cell Reports
- Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis
- (2012) Tanja Holopainen et al. JNCI-Journal of the National Cancer Institute
- Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
- (2012) Michael G. Schrauder et al. PLoS One
- Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma
- (2012) Antonio Diaz-Sanchez et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
- (2011) Roberta Mazzieri et al. CANCER CELL
- Angiopoietin-1 and -2 Exert Antagonistic Functions in Tumor Angiogenesis, yet Both Induce Lymphangiogenesis
- (2011) E. Fagiani et al. CANCER RESEARCH
- Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis: Figure 1.
- (2011) Michele De Palma et al. CLINICAL CANCER RESEARCH
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
- (2011) Jan Rykala et al. PATHOLOGY & ONCOLOGY RESEARCH
- Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular Leakage
- (2010) Young Jun Koh et al. CANCER CELL
- Induction of growth arrest by miR-542-3p that targets survivin
- (2010) Sena Yoon et al. FEBS LETTERS
- NFAT1 Mediates Placental Growth Factor-Induced Myelomonocytic Cell Recruitment via the Induction of TNF - α
- (2010) Yanping Ding et al. JOURNAL OF IMMUNOLOGY
- Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1 /CXCR4 Axis
- (2009) N. Song et al. CANCER RESEARCH
- Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
- (2009) Y. Huang et al. CANCER RESEARCH
- Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
- (2009) I. Helfrich et al. CLINICAL CANCER RESEARCH
- Influence of Pseudomonas aeruginosa quorum sensing signal molecule N-(3-oxododecanoyl) homoserine lactone on mast cells
- (2009) Hongtao Li et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
- (2009) Hellmut G. Augustin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNAs: Opening a New Vein in Angiogenesis Research
- (2009) J. E. Fish et al. Science Signaling
- Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells
- (2008) Yingbo He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More